Back to results
CompletedPhase 4

4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases

NCT02721433

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Ottawa Hospital Research Institute

Ottawa, Ontario, Canada

View on ClinicalTrials.gov
4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases — TrialFind